Variability in mesothelioma tumor response classification

American Journal of Roentgenology

Volumn 186, Issue 4, 2006, Pages 1000-1006

  Armato III, Samuel G ^a,b   Ogarek, Joseph L ^b   Starkey, Adam ^b   Vogelzang, Nicholas J ^c   Kindler, Hedy L ^b   Kocherginsky, Masha ^b   MacMahon, Heber ^a,b  

^a R2 Technology   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NEVADA CANCER INSTITUTE   (United States)

Author keywords

Computer aided diagnosis; CT; Lung cancer; Mesothelioma; Oncologic imaging; Tumor response

Indexed keywords

ADULT; AGED; ARTICLE; AUTOMATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; MEASUREMENT; MESOTHELIOMA; OBSERVER VARIATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THICKNESS; TUMOR CLASSIFICATION; CLASSIFICATION; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; OBSERVER VARIATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33646949799     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.05.0076     Document Type: Article

References (23)

1. Kindler HL, Vogelzang NJ. Mesothelioma. In: Vokes EE, Golomb HM, eds. Oncologic therapies. Berlin, Germany: Springer-Verlag, 2003:415-423
2. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21:2636-2644
3. Byrne MJ, Davidson JA, Musk AW, et al. Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study. J Clin Oncol 1999; 17:25-30
4. Steele JP, Shamash J, Evans MT, Gower NH, Tischkowitz MD, Rudd RM. Phase II study of vinorelbine in patients with malignant pleural mesothelioma. J Clin Oncol 2000; 18:3912-3917
5. Kindler HL. Moving beyond chemotherapy: novel cytostatic agents for malignant mesothelioma. Lung Cancer 2004; 45[suppl]:S125-S127
6. Kawashima A, Libshitz HI. Malignant pleural mesothelioma: CT manifestations in 50 cases. AJR 1990; 155:965-969
7. Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR 1999; 172:1039-1047
8. Marom EM, Erasmus JJ, Pass HJ, Patz EF Jr. The role of imaging in malignant pleural mesothelioma. Semin Oncol 2002; 29:26-35
9. Ng CS, Munden RF, Libshitz HI. Malignant pleural mesothelionia: the spectrum of manifestations on CT in 70 cases. Clin Radiol 1999; 54:415-421
10. Yilmaz UM, Utkaner G, Yalniz E, Kumcuoglu Z. Computed tomographic findings of environmental asbestos-related malignant pleural mesothelioma. Respirology 1998; 3:33-38
11. Saini S. Radiologic measurement of tumor size in clinical trials: past, present, and future. AJR 2001; 176:333-334
12. Miller AB, Hogestraeten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47:207-214
13. James K, Eisenhauer E, Christian M, et al. Measuring response in solid tumors : unidimensional versus bidimensional measurement. J Natl Cancer Inst 1999; 91:523-528
14. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000; 92:205-216
15. Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 2004; 15:257-260
16. Hopper KD, Kasales CJ, Van Slyke MA, Schwartz TA, TenHave TR, Jozefiak JA. Analysis of interobserver and intraobserver variability in CT tumor measurements. AJR 1996; 167:851-854
17. Erasmus JJ, Gladish GW, Broemeling L, et al. Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. J Clin Oncol 2003; 21:2574-2582
18. Thiesse P, Ollivier L, Di Stefano-Louineau D, et al. Response rate accuracy in oncology trials: reasons for interobserver variability. J Clin Oncol 1997; 15:3507-3514
19. Armato SG III, Oxnard GR, MacMahon H, et al. Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques. Med Phys 2004; 31:1105-1115
20. Aberle DR, Dionisio JDN, McNitt-Gray MF, et al. Integrated multimedia timeline of medical images and data for thoracic oncology patients. RadioGraphics 1996; 16:669-681
21. Sensakovic WF, Armato SG III, Starkey A, Ogarek JL. Automated matching of temporally sequential CT sections. Med Phys 2004; 31:3417-3424
22. Armato SG III, Oxnard GR, Kocherginsky M, Vogelzang NJ, Kindler HL, MacMahon H. Evaluation of semi-automated measurements of mesothelioma tumor thickness on CT scans. 2005 ; Acad Radiol 12:1301-1309
23. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-174